19776716

Source:http://linkedlifedata.com/resource/pubmed/id/19776716

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019189, umls-concept:C0019196, umls-concept:C0035525, umls-concept:C0035820, umls-concept:C0087111, umls-concept:C0152254, umls-concept:C0391001, umls-concept:C1305855
pubmed:issue	2
pubmed:dateCreated	2009-9-24
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0421110
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a, http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2a
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	0031-0808
pubmed:author	pubmed-author:AnsaldiFF, pubmed-author:BorroPP, pubmed-author:GentileRR, pubmed-author:IcardiGG, pubmed-author:RavettiGG, pubmed-author:SumberazAA, pubmed-author:TestiniMM
pubmed:issnType	Print
pubmed:volume	51
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	135-6
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:19776716-Adult, pubmed-meshheading:19776716-Antiviral Agents, pubmed-meshheading:19776716-Biopsy, pubmed-meshheading:19776716-Body Mass Index, pubmed-meshheading:19776716-Drug Therapy, Combination, pubmed-meshheading:19776716-Fatty Liver, pubmed-meshheading:19776716-Female, pubmed-meshheading:19776716-Hepatitis C, Chronic, pubmed-meshheading:19776716-Humans, pubmed-meshheading:19776716-Immunosuppressive Agents, pubmed-meshheading:19776716-Interferon-alpha, pubmed-meshheading:19776716-Liver Transplantation, pubmed-meshheading:19776716-Male, pubmed-meshheading:19776716-Middle Aged, pubmed-meshheading:19776716-Polyethylene Glycols, pubmed-meshheading:19776716-Prospective Studies, pubmed-meshheading:19776716-Recombinant Proteins, pubmed-meshheading:19776716-Recurrence, pubmed-meshheading:19776716-Ribavirin, pubmed-meshheading:19776716-Severity of Illness Index, pubmed-meshheading:19776716-Time Factors, pubmed-meshheading:19776716-Treatment Outcome, pubmed-meshheading:19776716-Viral Load
pubmed:year	2009
pubmed:articleTitle	Pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C: role of steatosis and body mass index.
pubmed:publicationType	Letter, Clinical Trial